Salvarani, Nicolò

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2017 | 2014 | 2011 | 2010 | 2009 | 2008

2017

Salvarani, Nicolò; Maguy, Ange; De Simone, Stefano Andrea; Miragoli, Michele; Jousset, Florian; Rohr, Stephan (2017). TGF-β 1 (Transforming Growth Factor-β 1 ) Plays a Pivotal Role in Cardiac Myofibroblast Arrhythmogenicity. Circulation - arrhythmia and electrophysiology, 10(5), e004567. Lippincott Williams & Wilkins 10.1161/CIRCEP.116.004567

2014

Grand, Teddy; Salvarani, Nicolò; Jousset, Florian; Rohr, Stephan (2014). Aggravation of cardiac myofibroblast arrhythmogeneicity by mechanical stress. Cardiovascular research, 104(3), pp. 489-500. Oxford University Press 10.1093/cvr/cvu227

2011

Rosker, Christian; Salvarani, Nicolò; Schmutz, Stephan; Grand, Teddy; Rohr, Stephan (2011). Abolishing myofibroblast arrhythmogeneicity by pharmacological ablation of α-smooth muscle actin containing stress fibers. Circulation research, 109(10), pp. 1120-1131. Baltimore, Md.: Lippincott Williams & Wilkins 10.1161/CIRCRESAHA.111.244798

Miragoli, Michele; Kadir, Siti H Sheikh Abdul; Sheppard, Mary N; Salvarani, Nicoló; Virta, Matilda; Wells, Sarah; Lab, Max J; Nikolaev, Viacheslav O; Moshkov, Alexey; Hague, William M; Rohr, Stephan; Williamson, Catherine; Gorelik, Julia (2011). A protective antiarrhythmic role of ursodeoxycholic acid in an in vitro rat model of the cholestatic fetal heart. Hepatology, 54(4), pp. 1282-92. Hoboken, N.J.: Wiley Interscience 10.1002/hep.24492

2010

Rosker, Christian; Salvarani, Nicolò; Rohr, Stephan (November 2010). Resveratrol reduces myofibroblast arrhythmogenicity. BMC Pharmacology, 10(Suppl), A3. BioMed Central 10.1186/1471-2210-10-S1-A3

Salvarani, Nicolò; Rosker, Christian; Rohr, Stephan (2010). Heterocellular crosstalk between myofibroblasts and cardiomyocytes: Arrhythmogenic effects of transforming growth factor-b1. In: Annual Meeting of the Swiss Physiological Society 2009. Bern, Switzerland. 9-10 Sep 2009.

Salvarani, N; Rosker, C; Rohr, S (2010). Electrotonic Crosstalk Between Cardiomyocytes and Myofibroblasts. Cardiovascular medicine Basel: EMH Swiss Medical Publishers Ltd

2009

Salvarani, N; Rosker, C; Miragoli, M; Rohr, S (2009). Effects of Cytokines on Electrophysiological Properties of Hybrid Cardiomyocyte-Myofibroblast Preparations. In: Gordon Research Conference 2009 on Cardiac Arrhythmia Mechanisms Gordon Research Conference 2009 on Cardiac Arrhythmia Mechanisms. Il Ciocco, Feb. 15-20, 2009.

Salvarani, N; Rosker, C; Miragoli, M; Rohr, S (2009). Effects of TGF- 1 on Electrophysiological Properties of Hybrid Cardiomyocyte-Myofibroblast Preparations. In: Ascona Workshop on Cardiomyocyte Biology 2009: Generation and Repair of Myocardial Tissue. Ascona , Apr. 26-30, 2009.

Salvarani, N; Rosker, C; Miragoli, M; Rohr, S (2009). Heterocellular Crosstalk Between Myofibroblasts and Cardiomyocytes: Arrhythmogenic Effects of Transforming Growth Factor- 1. In: Meeting of the Swiss Physiological Society 2009. Bern, Sept., 2009.

Salvarani, N; Rosker, C; Rohr, S (2009). Heterocellular Crosstalk Between Myofibroblasts and Cardiomyocytes: Arrhythmogenic Effects of Transforming Growth Factor- 1. In: DKF 2009. Day of Clinical Research meeting. Bern, Nov. 11, 2009.

Salvarani, N; Rosker, C; Miragoli, M; Rohr, S (2009). Arrhythmogenic Effects of Transforming Growth Factor- 1 on Hybrid Cardiomyocyte-Myofibroblast Preparations. In: AHA 2009. American Heart Association. Orlando, Nov. 14-18, 2009.

Rosker, Christian; Salvarani, Nicolò; Rohr, Stephan (2009). Reducing Myofibroblast Arrhythmogeneicity by Pharmacological Targeting of Their Cytoskeleton. Circulation, 120, S635; abstract 2424. Lippincott Williams & Wilkins

Salvarani, N; Rosker, C; Rohr, S (2009). Arrhythmogenic Effects of Transforming Growth Factor- 1 on Hybrid Cardiomyocyte-Myofibroblast Preparations. Circulation, 120, S635; abstract 2427. Baltimore, Md.: Lippincott Williams & Wilkins

Rosker, Christian; Salvarani, Nicolò; Rohr, Stephan (2009). Modification of Actin Fibers Changes the Electrical Phenotype of Cardiac Myofibroblasts. BMC pharmacology, 9(Supple), A15. London: BioMed Central 10.1186/1471-2210-9-S2-A15

2008

Salvarani, N; Miragoli, M; Rohr, S (2008). Effects of cytokines on electrophysiological properties of hybrid cardiomyocyte-myofibroblast preparation. In: Annual meeting of the Swiss Cardiovascular Research and Training Network, Bern. 2008.

Provide Feedback